961|1710|Public
25|$|Chitosan and chitin {{belong to}} a family of biopolymers {{composed}} of β(1–4)-linked N-acetyl-D-glucosamine and D-glucosamine subunits. Chitosan is formed by alkaline N-deacetylation of chitin, which {{is the second most}} abundant natural polymer after cellulose. Chitosan is a biodegradable polysaccharide that has been useful in many biomedical applications such as a chelating agent, <b>drug</b> <b>carrier,</b> membrane, and water treatment additive. Chitosan is soluble in dilute aqueous solutions, but precipitates into a gel at a neutral pH. It does not support neural cell attachment and proliferation well, but can be enhanced by ECM-derived peptide attachment. Chitosan also contains weak mechanical properties, which are more challenging to overcome.|$|E
2500|$|Lipids are an {{integral}} part of our daily diet. Most oils and milk products that we use for cooking and eating like butter, cheese, ghee etc., are composed of fats. Vegetable oils are rich in various polyunsaturated fatty acids (PUFA). Lipid-containing foods undergo digestion within the body and are broken into fatty acids and glycerol, which are the final degradation products of fats and lipids. [...] Lipids, especially phospholipids, are also used in various pharmaceutical products, either as co-solubilisers (e.g., in [...] infusions) or else as <b>drug</b> <b>carrier</b> components (e.g., in a liposome or transfersome).|$|E
50|$|They {{were used}} as a <b>drug</b> <b>carrier</b> {{mechanism}} for experimental cancer therapies.|$|E
40|$|Extent of {{therapeutic}} action of drug {{depends on its}} absorption which interns depends on the concentration of drug at the absorption site. Targeted drug delivery system is now regarded as 4 th generation drug delivery and API shall be targeted to the required site by variety of <b>drug</b> <b>carriers.</b> Since last three decades researchers have developed different types of <b>drug</b> <b>carriers.</b> This article briefs about different <b>drug</b> <b>carriers</b> and their applications and limitations...|$|R
50|$|There are {{different}} types of drug delivery vehicles, such as polymeric micelles, liposomes, lipoprotein-based <b>drug</b> <b>carriers,</b> nano-particle <b>drug</b> <b>carriers,</b> dendrimers, etc. An ideal drug delivery vehicle must be non-toxic, biocompatible, non-immunogenic, biodegradable, and must avoid recognition by the host's defense mechanisms3.|$|R
40|$|Bacterial magnetosomes (BMs) {{synthesized}} by {{magnetotactic bacteria}} have recently drawn great interest {{due to their}} unique features. BMs are used experimentally as carriers for antibodies, enzymes, ligands, nucleic acids, and chemotherapeutic drugs. In addition to the common attractive properties of magnetic carriers, BMs also show superiority as targeting nanoscale <b>drug</b> <b>carriers,</b> which is hardly matched by artificial magnetic particles. We are presenting the potential applications of BMs as <b>drug</b> <b>carriers</b> by introducing the drug-loading methods and strategies and the recent research progress of BMs which {{has contributed to the}} application of BMs as <b>drug</b> <b>carriers...</b>|$|R
50|$|Porous beta-Tricalcium {{phosphate}} scaffolds {{are employed}} as <b>drug</b> <b>carrier</b> systems for local drug delivery in bone.|$|E
50|$|Successful {{delivery}} of therapeutics to the intended target largely {{depends on the}} choice of the <b>drug</b> <b>carrier.</b> The criteria for an ideal <b>drug</b> <b>carrier</b> include maximum effect upon {{delivery of}} the drug to the target organ, evasion of the immune system of the body in the process of reaching the organ, retention of the therapeutic molecules from preparatory stages to the final delivery of the drug, and proper release of the drug for exertion of the intended therapeutic effect.|$|E
50|$|A {{wide variety}} of <b>drug</b> <b>carrier</b> systems have been {{developed}} and studied, {{each of which has}} unique advantages and disadvantages. Some of the more popular types of drug carriers include liposomes, polymeric micelles, microspheres, and nanoparticles. Different methods of attaching the drug to the carrier have been implemented, including adsorption, integration into the bulk structure, encapsulation, and covalent bonding. Different types of <b>drug</b> <b>carrier</b> utilize different methods of attachment, and some carriers can even implement a variety of attachment methods.|$|E
40|$|We have {{prepared}} self-assembled polymeric <b>drug</b> <b>carriers</b> containing fluorophore and loaded drugs for theragnostic imaging of tumors. This {{new type of}} polymeric <b>drug</b> <b>carriers</b> visualizes the accumulation of carriers at tumor sites, and evaluates therapeutic efficacies, and thereby providing an exciting new tool for monitering tumor diagnosis and therapy. 1...|$|R
5000|$|Chair, Gordon Conference on <b>Drug</b> <b>Carriers</b> in Medicine and Biology (2004) ...|$|R
30|$|Summarizing {{the above}} {{described}} {{progress in the}} studies on the application of CNTs as <b>drug</b> <b>carriers,</b> it may be seen that the chemistry on the modification of CNTs now has considerably grown up. The previous studies have provided us various chemical methods to solve some fundamental problems {{in the use of}} CNTs as <b>drug</b> <b>carriers</b> such as their water solubility and target properties. Many reported results, including those obtained from in vitro and in vivo experiments, have demonstrated that CNTs can increase the treatment effects while decrease the side and toxic effects of the drugs loaded on them, indicating a considerably bright future for them to be used as <b>drug</b> <b>carriers.</b> However, there is {{a long way to go}} for CNTs to get into practical use. Particularly, the pharmacological and toxicological profiles must be made completely clear and the advantages and the disadvantages of CNTs must be carefully weighed before they are used as <b>drug</b> <b>carriers</b> in human body.|$|R
50|$|Multiple {{cellular}} stimuli could induce {{responses in}} supramolecular polymers. The dynamic molecular skeletons of supramolecular polymers can be depolymerized when exposing {{to the external}} stimuli like pH in vivo. On {{the basis of this}} property, supramolecular polymers are capable of being a <b>drug</b> <b>carrier.</b> Making use of hydrogen bonding between nucleobases to induce self-assemble into pH-sensitive spherical micelles.|$|E
50|$|In {{a broader}} sense, a Transfersome {{is a highly}} adaptable, stress-responsive complex aggregate. The form {{preferred}} by researchers and pharmacologists is an ultradeformable vesicle possessing an aqueous core surrounded by the complex lipid bilayer. Interdependencies inherent in the local composition {{and shape of the}} bilayer makes the vesicle both self-regulating and self-optimizing. This enables the Transfersome to cross various transport barriers efficiently, and then act as a <b>Drug</b> <b>carrier</b> for non-invasive targeted drug delivery and sustained release of therapeutic agents.|$|E
50|$|Nanotechnology is {{expected}} to revolutionize ocular drug delivery. Many nano-structured systems have been employed for ocular drug delivery and yielded some promising results. SLNs have been looked at as a potential <b>drug</b> <b>carrier</b> system since the 1990s. SLNs do not show biotoxicity as they are prepared from physiological lipids. SLNs are especially useful in ocular drug delivery as they can enhance the corneal absorption of drugs and improve the ocular bioavailability of both hydrophilic and lipophilic drugs. Solid lipid nanoparticles have another advantage of allowing autoclave sterilization, a necessary step towards formulation of ocular preparations.|$|E
30|$|Liposomes are {{man-made}} vesicles {{consisting of}} a phospholipid bilayer [1]. Since the 1970 s, liposomes have been extensively investigated as <b>drug</b> <b>carriers</b> because of their biocompatibility and ability to deliver both hydrophilic and hydrophobic therapeutic agents. They are the most successful <b>drug</b> <b>carriers</b> with over 40 liposome-based therapeutics either in market (e.g., Doxil®, Ambisome®, and DepoDur™) or in various phases of clinical trials [2, 3].|$|R
30|$|After all, {{the studies}} on the {{application}} of CNTs as <b>drug</b> <b>carriers</b> {{for the treatment of}} cancers have achieved important progress. Some key obstacles in the way to practical use have been overcome. Although there {{is still a long way}} to go for the practical use, it may be predicted that, on one day in the future, CNTs will become an important class of <b>drug</b> <b>carriers</b> for cancer treatment.|$|R
50|$|The {{copolymers}} obtained {{can be used}} as biocompatible <b>drug</b> <b>carriers,</b> in coatings and adhesives, and in {{many other}} applications.|$|R
5000|$|Lipids are an {{integral}} part of our daily diet. Most oils and milk products that we use for cooking and eating like butter, cheese, ghee etc., are composed of fats. Vegetable oils are rich in various polyunsaturated fatty acids (PUFA). Lipid-containing foods undergo digestion within the body and are broken into fatty acids and glycerol, which are the final degradation products of fats and lipids. Lipids, especially phospholipids, are also used in various pharmaceutical products, either as co-solubilisers (e.g., in [...] infusions) or else as <b>drug</b> <b>carrier</b> components (e.g., in a liposome or transfersome).|$|E
50|$|Rod or tube-like, {{rather than}} nearly spherical, nanocarriers may offer {{additional}} advantages {{in terms of}} drug delivery systems. Such <b>drug</b> <b>carrier</b> particles possess additional choice of the axial ratio, the curvature, and the “all-sweeping” hydrodynamic-related rotation, {{and they can be}} modified chemically at the inner surface, the outer surface, and at the end planes in a very selective way. Nanotubes prepared with a responsive polymer attached to the tube opening allow the control of access to and release from the tube. Furthermore, nanotubes can also be prepared showing a gradient in its chemical composition {{along the length of the}} tube.|$|E
50|$|The {{emergence}} of nanocomposite hydrogels allow for more site-specific and time-controlled delivery of drugs {{of different sizes}} at improved safety and specificity. Depending on the method of inserting drugs into the material, for example, dissolved, encased, or attached, the <b>drug</b> <b>carrier</b> will be named differently: nanoparticles, nanospheres (where the drug is evenly dispersed throughout the polymeric network), or nanocapsules (where the drug {{is surrounded by a}} polymer shell structure). The elastomeric nature of this material allows the hydrogels to obtain the shape of the targeted site and thus the hydrogels can be manufactured identically and used on all patients.|$|E
40|$|Glycol {{chitosan}} (GC) and its derivatives {{have been}} extensively investigated as {{safe and effective}} <b>drug</b> delivery <b>carriers</b> because of their unique physiochemical and biological properties. The reactive functional {{groups such as the}} amine and hydroxyl groups on the GC backbone allow for easy chemical modification with various chemical compounds (e. g., hydrophobic molecules, crosslinkers, and acid-sensitive and labile molecules), and the versatility in chemical modifications enables production {{of a wide range of}} GC-based <b>drug</b> <b>carriers.</b> This review summarizes the versatile chemical modification methods that can be used to design GC-based <b>drug</b> <b>carriers</b> and describes their recent applications in disease therapy...|$|R
5000|$|Polyethylene glycolcould bind to the {{hydrophobic}} surface of SWNHs {{to enhance their}} dispersibility in water for further application in drug delivery. [...] Adsorption of polyethylene glycol-doxorubicin (PEG-DXR) conjugate onto SWNHox could form a water-soluble nanocomposite. SWNHs served as <b>drug</b> <b>carriers</b> to realize local cancel chemotherapy. When injected intratumorally, PEG-DXR SWNHs caused significant retardation of tumor growth associated with prolonged DXR retention in the tumor, showing that water-dispersed SWNHs were useful <b>drug</b> <b>carriers</b> for local chemotherapy.|$|R
30|$|As <b>drug</b> <b>carriers,</b> {{they will}} be finally used in living animals and human. Although {{the results of the}} in vitro {{experiments}} have provided a lot of useful information about the application of CNTs as <b>drug</b> <b>carriers,</b> only the in vivo experiments can give corroboration for the usefulness of CNTs in practical gene delivery for cancer therapies. However, there have been only limited in vivo studies reported on the application of CNTs as the molecular transporter in drug delivery.|$|R
50|$|Chitosan and chitin {{belong to}} a family of biopolymers {{composed}} of β(1-4)-linked N-acetyl-D-glucosamine and D-glucosamine subunits. Chitosan is formed by alkaline N-deacetylation of chitin, which {{is the second most}} abundant natural polymer after cellulose. Chitosan is a biodegradable polysaccharide that has been useful in many biomedical applications such as a chelating agent, <b>drug</b> <b>carrier,</b> membrane, and water treatment additive. Chitosan is soluble in dilute aqueous solutions, but precipitates into a gel at a neutral pH. It does not support neural cell attachment and proliferation well, but can be enhanced by ECM-derived peptide attachment. Chitosan also contains weak mechanical properties, which are more challenging to overcome.|$|E
50|$|A <b>drug</b> <b>carrier</b> is any {{substrate}} used in {{the process}} of drug delivery which serves to improve the selectivity, effectiveness, and/or safety of drug administration. Drug carriers are primarily used to control the release of a drug into systemic circulation. This can be accomplished either by slow release of the drug {{over a long period of}} time (typically diffusion) or by triggered release at the drug's target by some stimulus, such as changes in pH, application of heat, and activation by light. Drug carriers are also used to improve the pharmacokinetic properties, specifically the bioavailability, of many drugs with poor water solubility and/or membrane permeability.|$|E
5000|$|Since it is {{too large}} to diffuse through the skin, the Transfersome [...] must find and exploit a {{suitable}} route through the organ. Use of Transfersome vesicles for drug delivery therefore relies on the carrier’s ability to widen and overcome the hydrophilic pores in the skin or some other (e.g. plant cuticle) opening. The subsequent gradual release of the active agent from the <b>drug</b> <b>carrier</b> allows the drug molecules to diffuse and finally bind to their targets. Drug transport to an intra-cellular action site may also involve fusion of the carrier’s lipid bilayer with the cell membrane, unless the vesicle is taken up actively by the cell in the process called endocytosis.|$|E
30|$|Herein, the CDA-AMB-NPs might {{step up the}} {{development}} of systemically administered and targeted <b>drug</b> <b>carriers</b> that can potentially treat systemic candidiasis infection associated with acidity.|$|R
30|$|However, these {{polymers}} {{are characterized}} by a high hydrophobicity and slow degradation rate that can represent in some cases a disadvantage for their use as <b>drug</b> <b>carriers</b> [7].|$|R
30|$|Distribution {{indicates}} the sites or places the absorbed CNTs can arrive and exist there, which are {{of great importance}} in clinical pharmacology and toxicology of CNTs as <b>drug</b> <b>carriers.</b>|$|R
50|$|Biodegradable {{polymers}} are {{of great}} interest {{in the field of}} drug delivery and nanomedicine. The great benefit of a biodegradable drug delivery system is the ability of the <b>drug</b> <b>carrier</b> to target the release of its payload to a specific site in the body and then degrade into nontoxic materials that are then eliminated from the body via natural metabolic pathways. The polymer slowly degrades into smaller fragments, releasing a natural product, and there is controlled ability to release a drug. The drug slowly releases as polymer degrades. For example, polylactic acid, poly(lactic-co-glycolic) acid, and poly(caprolactone), all of which are biodegradable, have been used to carry anti-cancer drugs. Encapsulating the therapeutic in a polymer and adding targeting agents decreases the toxicity of the drug to healthy cells.|$|E
5000|$|Natural fibers often show {{promise as}} {{biomaterials}} in medical applications. Chitin is notable {{in particular and}} has been incorporated {{into a variety of}} uses. Chitin based materials have also been used to remove industrial pollutants from water, processed into fibers and films, and used as biosensors in the food industry. [...] Chitin has also been used several of medical applications. It has been incorporated as a bone filling material for tissue regeneration, a <b>drug</b> <b>carrier</b> and excipient, and as an antitumor agent. [...] Insertion of foreign materials into the body often triggers an immune response, which can have a variety of positive or negative outcomes depending on the bodies response to the material. Implanting something made from naturally synthesized proteins, such as a keratin based implant, {{has the potential to be}} recognized as natural tissue by the body. This can lead either to integration in rare cases where the structure of the implant promotes regrowth of tissue with the implant forming a superstructure or degradation of the implant in which the backbones of the proteins are recognized for cleavage by the body.|$|E
5000|$|The {{final act}} begins with Willie and Eddie, {{on their way}} back to New York, {{deciding}} instead to go to Florida. They turn around and [...] "rescue" [...] Eva. The three of them get to Florida and get a room at a motel. The two men leave Eva in the Motel-room and end up losing all of their money on dog races. Eva wanders outside in the windy bleak rainy afternoon to the beach--which appears not much more appealing than the windy bleak snowy Lake Erie scene from which they fled, in Cleveland. When they come back Eva is annoyed. At this point, Willy and Eddie decide to go back and bet on horse races. Willie refuses to let Eva come along, so she goes out on the beach for a walk. Given her flamboyant wide-brimmed straw hat, she is mistaken by a <b>drug</b> <b>carrier</b> to be a dealer waiting to be paid, and is given a large sum of money. She goes back to the motel, leaves some of the money for Willie and Eddie, and writes them a note explaining that she is going to the airport. Willie and Eddie, having won all of their money back at the horse races, return to the motel, and find Eva is gone. Willie reads her note and they go to the airport to stop her from leaving. We see Eva conversing with the airline employee about various options for flying to Europe, ending with a mention that there is a plane leaving in 44 minutes for her home city of Budapest. She appears indecisive. When Willie and Eddie get to the airport, Willie conceives a plan: buy a ticket to Budapest, get on the plane, and convince Eva to stay in the United States. The second to last shot shows Eddie outside watching the plane flying overhead, lamenting that Willie was apparently not able to get off the plane and that now both Willie and Eva are headed to Budapest. The final shot, however, shows Eva back at the motel, returning to an empty room, toying with the striped straw hat.|$|E
40|$|Amphiphilic block {{copolymers}} {{are well}} established as {{building blocks for}} the preparation of micellar <b>drug</b> <b>carriers.</b> Over the past decade, the effectiveness of such self-assembled drug delivery devices has been demonstrated numerous times. This review will discuss two approaches {{that can be used}} to further improve the effectiveness of amphiphilic block copolymer-based drug delivery systems. The first approach involves the chemical modification of the block copolymer building blocks. Several examples will be discussed of amphiphilic block copolymers modified with crosslinkable groups in order to increase the stability of the micellar <b>drug</b> <b>carriers,</b> or of block copolymers containing specific ligands that could ultimately allow targeted drug delivery. The second approach to improve the performance of micellar <b>drug</b> <b>carriers</b> is the addition of auxiliary agents. To illustrate this approach, the feasibility of channel proteins and metal (nano) particles to improve temporal control over the drug release process is discussed. © 2001 Elsevier Science B. V. All rights reserved...|$|R
40|$|The {{past two}} decades have {{witnessed}} the great growth {{of the development of}} novel <b>drug</b> <b>carriers.</b> However, the releasing dynamics of <b>drug</b> from <b>drug</b> <b>carriers</b> in vivo and the interactions between cells and <b>drug</b> <b>carriers</b> remain unclear. In this paper, liposomes were prepared to encapsulate D-luciferin, which was the substrate of luciferase and served as a model drug. Based on the theoretical calculation of active loading, methods of preparation for liposomes were optimized. Only when D-luciferin was released from liposomes or taken in by the cells could bioluminescence be produced under the catalysis of luciferase. Models of multicellular tumor spheroid (MCTS) were built with 4 T 1 -luc cells that expressed luciferase stably. The kinetic processes of uptake and distribution of free drugs and liposomal drugs were determined with models of cell suspension, monolayer cells, MCTS, and tumor-bearing nude mice. The technology platform has been demonstrated to be effective {{for the study of the}} distribution and kinetic profiles of various liposomes as drug delivery systems...|$|R
50|$|Although S1P {{is active}} {{at very low}} concentrations, {{bioavailability}} of the compound in human skin is a concern. Therefore, a topical formulation based on specific <b>drug</b> <b>carriers</b> has been considered inevitable.|$|R
